Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulizing Crohn's Disease

Documents similaires

• Editorial: Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulising Crohn's Disease. Authors' Reply
  par: Runqi Wang, et autres
  Publié: (2026)
• Letter: Putting Crohn's Risk Prediction to Work in Perianal Fistula—Calibration, Thresholds, and Transport
  par: Emmanuel Pio Pastore
  Publié: (2025)
• Editorial: Upadacitinib in Perianal Crohn's Disease
  par: Manjeet Kumar Goyal, et autres
  Publié: (2026)
• Editorial: Development and Validation of a Multimodal Machine Learning Model for Diagnosing and Assessing Risk of Crohn's Disease in Patients With Perianal Fistula
  par: Alyssa M. Parian, et autres
  Publié: (2025)
• Editorial: Development and Validation of a Multimodal Machine Learning Model for Diagnosing and Assessing Risk of Crohn's Disease in Patients With Perianal Fistulae: Authors' Reply
  par: Lichao Qiao, et autres
  Publié: (2025)